Curley Steven A, Izzo Francesco, Abdalla Eddie, Vauthey J Nicholas
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center Houston, Texas, USA.
Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):165-82. doi: 10.1023/a:1025875332255.
Colorectal cancer is one of the most common solid tumors affecting people around the world. A significant proportion of patients with colorectal cancer will develop or will present with liver metastases. In some of these patients, the liver is the only site of metastatic disease. Thus, surgical treatment approaches are an appropriate and important treatment option in patients with liver-only colorectal cancer metastases. Resection of colorectal cancer liver metastases can produce long-term survival in selected patients, but the efficacy of liver resection as a solitary treatment is limited by two factors. First, a minority of patients with liver metastases have resectable disease. Second, the majority of patients who undergo successful liver resection for colorectal cancer metastases develop recurrent disease in the liver, extrahepatic sites, or both. In this paper, in addition to the results of liver resection for colorectal cancer metastases, we will review the results of thermal ablation. Each of these surgical treatment modalities can produce long-term survival in a subset of patients with liver-only colorectal cancer metastases, whereas administration of systemic or regional chemotherapy rarely results in long-term survival in these patients. While surgical treatments provide the best chance for long-term survival or, in some cases, the best palliation in patients with colorectal cancer liver metastases, it is clear that further improvements in patient outcome will require multimodality therapy regimens. Modern surgical treatment of colorectal liver metastases can be performed safely with low mortality and transfusion rates, and surgical treatment should be considered in patients with disease confined to their liver.
结直肠癌是影响全球人群的最常见实体瘤之一。相当一部分结直肠癌患者会发生或出现肝转移。在这些患者中,有些患者肝脏是唯一的转移病灶部位。因此,手术治疗方法对于仅发生肝转移的结直肠癌患者而言是一种合适且重要的治疗选择。切除结直肠癌肝转移灶可使部分患者获得长期生存,但肝切除作为单一治疗手段的疗效受到两个因素的限制。其一,少数肝转移患者的病灶可切除;其二,大多数因结直肠癌肝转移而成功接受肝切除的患者会在肝脏、肝外部位或两者同时出现复发。在本文中,除了结直肠癌肝转移灶肝切除的结果外,我们还将回顾热消融的结果。这些手术治疗方式中的每一种都能使部分仅发生肝转移的结直肠癌患者获得长期生存,而全身或区域化疗在这些患者中很少能带来长期生存。虽然手术治疗为结直肠癌肝转移患者提供了最佳的长期生存机会,或在某些情况下提供了最佳的姑息治疗,但显然进一步改善患者预后需要多模式治疗方案。现代结直肠癌肝转移的手术治疗可以安全地进行,死亡率和输血率较低,对于病灶局限于肝脏的患者应考虑手术治疗。